A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
Source: curetoday.com
Advanced Cervical News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Advanced Cervical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Advanced Cervical Today - Breaking & Trending Today
Keytruda Plus CRT Offers 'Better Chance of Cure' in Advanced Cervical Cancer
The Food and Drug Administration (FDA) has recently approved Keytruda (pembrolizumab) plus chemoradiotherapy for the treatment of patients with stages 3 to 4A cervical cancer.
Source: curetoday.com
FDA Accepts sBLA For Tivdak In Recurrent or Metastatic Cervical Cancer
The Food and Drug Administration has accepted a supplemental Biologics License Application (sBLA) intended to convert the accelerated approval granted to Tivdak (tisotumab vedotin-tftv) in 2021 to full approval for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after first-line therapy.
Source: curetoday.com
Second Remission Likely After Retreatment With Keytruda for Patients with Hodgkin Lymphoma
A phase 2 trial found that some patients with classical Hodgkin lymphoma saw a nearly 74% probability of second remission due to retreatment with Keytruda.
Source: curetoday.com